For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Exact Sciences Corp (NASDAQ: EXAS) was $47.54 for the day, down -1.04% from the previous closing price of $48.04. In other words, the price has decreased by -$1.04 from its previous closing price. On the day, 2.16 million shares were traded. EXAS stock price reached its highest trading level at $48.074 during the session, while it also had its lowest trading level at $46.97.
Ratios:
Our analysis of EXAS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.41 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 46.19. For the most recent quarter (mrq), Quick Ratio is recorded 2.38 and its Current Ratio is at 2.73. In the meantime, Its Debt-to-Equity ratio is 1.06 whereas as Long-Term Debt/Eq ratio is at 1.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on April 10, 2025, initiated with a Outperform rating and assigned the stock a target price of $60.
On March 13, 2025, RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and target price of $52.
On January 23, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $70.Barclays initiated its Overweight rating on January 23, 2025, with a $70 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 16 ’25 when Sebelius Kathleen bought 8,164 shares for $53.11 per share.
Zanotti Katherine S sold 3,207 shares of EXAS for $170,612 on Jun 13 ’25. The Director now owns 72,759 shares after completing the transaction at $53.20 per share. On Jun 13 ’25, another insider, Zanotti Katherine S, who serves as the Director of the company, bought 3,207 shares for $53.20 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXAS now has a Market Capitalization of 8967851008 and an Enterprise Value of 10720744448. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.17 while its Price-to-Book (P/B) ratio in mrq is 3.74. Its current Enterprise Value per Revenue stands at 3.791 whereas that against EBITDA is 281.443.
Stock Price History:
The Beta on a monthly basis for EXAS is 0.92, which has changed by 0.04071808 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, EXAS has reached a high of $72.83, while it has fallen to a 52-week low of $39.97. The 50-Day Moving Average of the stock is -11.18%, while the 200-Day Moving Average is calculated to be -11.92%.
Shares Statistics:
EXAS traded an average of 2.91M shares per day over the past three months and 1981850 shares per day over the past ten days. A total of 188.59M shares are outstanding, with a floating share count of 186.20M. Insiders hold about 1.29% of the company’s shares, while institutions hold 97.28% stake in the company. Shares short for EXAS as of 1752537600 were 7467057 with a Short Ratio of 2.56, compared to 1749772800 on 7931112. Therefore, it implies a Short% of Shares Outstanding of 7467057 and a Short% of Float of 4.5300003.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
